IRAK decomposing agents and their use

JP7873243B2Active Publication Date: 2026-06-11KYMERA THERAPEUTICS INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2023540019
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-12-30
Filing Date
2021-12-30
Publication Date
2026-06-11
Estimated Expiration
2041-12-30

Smart Images

  • Figure 0007873243000001
    Figure 0007873243000001
  • Figure 0007873243000002
    Figure 0007873243000002
  • Figure 0007873243000003
    Figure 0007873243000003
Patent Text Reader

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.The compounds provided by the present invention are also useful for the study of IRAK enzyme in biological and pathological phenomena; the study of intracellular signaling pathways occurring in body tissues; and the comparative evaluation of novel IRAK inhibitors or IRAK degraders, or other regulators of kinase, signaling pathways, and cytokine levels in vitro or in vivo.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Heteroaryl-Substituted Aminopyridine Compounds

    JP2018522859A

  • IRAK decomposers and their uses

    JP2023552827A

  • IRAK degraders and uses thereof

    WO2019133531A1

  • IRAK degraders and uses thereof

    WO2020113233A1